HB1670, titled the Family Building FEHB Fairness Act, would require Federal Employees Health Benefits (FEHB) plans to cover fertility treatment benefits. The bill amends title 5 of the U.S. Code to add “fertility treatment benefits” as a required benefit category in FEHB plans, which are the health plans available to federal employees, retirees, and their dependents.
The bill defines fertility treatment broadly. Covered services would include preservation of oocytes, sperm, or embryos; artificial insemination; assisted reproductive technology such as in vitro fertilization; genetic testing of embryos; fertility-related medications; gamete donation; and other fertility-related services, treatments, and referrals that the Office of Personnel Management, in coordination with the Department of Health and Human Services, determines appropriate. The amendments would take effect one year after enactment.
Impact
If enacted, the bill would change federal law governing FEHB plan offerings by requiring fertility treatment coverage as part of the standard benefits structure. It would direct the Office of Personnel Management to administer the new coverage category and, with HHS, determine additional covered fertility-related services. The practical effect would be to expand insurance access for federal workers, retirees, and covered family members seeking infertility and family-building care, while increasing obligations for FEHB carriers and potentially affecting premiums and plan design.
Sentiment
The available context shows limited formal debate or recorded votes, so there is no clear evidence of organized opposition or support in committee proceedings. The bill’s title, sponsors, and subject matter suggest a generally pro-family-building, pro-access posture, and the absence of objections in the provided action history indicates the measure was at least procedurally noncontroversial at the point reflected here. Overall, the bill appears to have been framed as a benefits expansion for federal employees rather than a partisan restructuring of the FEHB program.
Contention
The main likely points of contention are the scope and cost of mandated fertility coverage. Supporters would likely emphasize access to IVF, embryo preservation, and other assisted reproductive technologies for federal workers and their families, while critics may focus on premium impacts, whether coverage should include elective or advanced reproductive services, and the inclusion of embryo genetic testing and gamete donation. Another possible issue is the delegation of authority to OPM and HHS to define additional covered services, which could raise questions about how expansive the benefit becomes over time.